Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) — The report “Global Cat Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated), Disease Type, Route of Administration, Duration of Immunity, Component, Region, and Segment Forecasts, 2024-2030” has been added to The Offer.
The global feline vaccines market is expected to reach $2.5 billion by 2030, growing at a compound annual growth rate of 9.4% from 2024 to 2030.
The increasing pet population, emerging cat diseases and increasing disposable income are expected to increase the market value of cat vaccines. In addition, investments by the pharmaceutical industry are also expected to boost market growth.
The rising market trend is due to the growing awareness among pet owners about the need for cat vaccinations, promoting preventative healthcare and ensuring the well-being of their cats. Pet owners today value products that meet the nutritional needs and personal values of their pets and are turning to online pet brands for convenient access to high-quality and nutritious pet supplies.
Highlights of the Cat Vaccines Market Report
- Based on vaccine type, the live attenuated vaccine segment dominated the market with the largest revenue share of 50.1% in 2023. The proven efficacy of live attenuated vaccines against feline panleukopenia and herpes virus has boosted the confidence of both pet owners and veterinarians.
- Based on disease type, the feline respiratory diseases (FRDs) segment accounted for the largest share of 32.4% in 2023, owing to the increasing prevalence of FRDs, which ultimately drove the market growth.
- The feline leukemia segment is expected to witness the highest CAGR of 9.8% during the forecast period.
- Based on the route of administration, the injectable drug segment accounted for the largest market share of 77.4% in 2023. Continuous research and development in vaccine technology is driving the injectable drug segment in the market.
- Based on duration of immunity, the 1-year segment had the largest market share at 50.1% in 2023, and the careful and evidence-based practices of veterinary organizations such as the American Association of Feline Practitioners (AAFP) guide the development of safe and effective vaccines.
- Based on components, the combined vaccine segment held the largest market share of 64.0% in 2023 and is expected to register the highest CAGR of 9.5% during the forecast period.
- In 2023, North America dominated the market with a revenue share of 38.1% due to strict regulations on animal vaccines and compliance with high-quality standards in feline health care.
Featured companies
- Virbac
- CH Boehringer Sohn AG & Co. KG.
- Elanco
- Zoetis
- Merck & Co.
- Bioveta, as
- Indian Immunologicals Ltd
Main features:
| Report Attribute | Details |
| Number of pages | 100 |
| Forecast period | 2023 – 2030 |
| Estimated market value (USD) in 2023 | 1.34 billion US dollars |
| Projected market value (USD) until 2030 | 2.5 billion US dollars |
| Average annual growth rate | 9.4% |
| Regions covered | Generally |
Main topics covered:
Chapter 1. Methodology and scope
Chapter 2. Summary
2.1. Market outlook
2.2. Segment outlook
2.3. Insights into the competition
Chapter 3. Cat Vaccines Market Variables, Trends and Scope
3.1. Market outlook
3.1.1. Market outlook for the parent company
3.1.2. Related/complementary market prospects
3.2. Market dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing number of pets
3.2.1.2. Emerging diseases in cats
3.2.1.3. Rising disposable income
3.2.1.4. Investments by the pharmaceutical industry
3.2.2. Analysis of market restrictions
3.2.2.1. Strict regulatory guidelines and rules
3.2.2.2. High costs for vaccines
3.3. Tools for market analysis for cat vaccines
3.3.1. Industry analysis – Porter's
3.3.2. PESTEL analysis
Chapter 4. Feline Vaccines Market: Vaccine Type Estimates and Trend Analysis
4.1. Market share by vaccine type, 2023 and 2030
4.2. Segment Dashboard
4.3. Global Cat Vaccines Market by Vaccine Type
4.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
4.4.1. Modified/muted (live)
4.4.2. Inactivated (killed)
4.4.3. Miscellaneous
Chapter 5. Feline Vaccines Market: Disease Type Estimates and Trend Analysis
5.1. Market share by disease type, 2023 and 2030
5.2. Segment Dashboard
5.3. Global cat vaccines market by disease type
5.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
5.4.1. Feline leukemia
5.4.2. Feline panleukopenia (distemper)
5.4.3. Respiratory diseases in cats
5.4.4. Rabies in cats
5.4.5. Other diseases
Chapter 6. Feline Vaccines Market: Estimates and Trend Analysis on Routes of Administration
6.1. Market share of administration routes, 2023 and 2030
6.2. Segment Dashboard
6.3 Global Cat Vaccines Market – Outlook by Route of Administration
6.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
6.4.1. Injections
6.4.2. Intranasal
6.4.3. Oral
Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates and Trend Analysis
7.1 Duration of immunity market share, 2023 and 2030
7.2. Segment Dashboard
7.3. Global cat vaccine market by duration of immunity
7.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
7.4.1. 1 year
7.4.2. 3 years
7.4.3. Miscellaneous
Chapter 8. Cat Vaccines Market: Component Estimates and Trend Analysis
8.1. Component market share, 2023 and 2030
8.2. Segment Dashboard
8.3. Global Cat Vaccines Market by Component
8.4. Market size & forecasts and trend analysis, 2018 to 2030 for the following
8.4.1. Combination vaccine
8.4.2. Monovaccine
Chapter 9. Cat Vaccines Market: Regional Estimates and Trend Analysis
9.1. Regional market share analysis, 2023 and 2030
9.2. Regional Market Dashboard
9.3. Global regional market overview
9.4. Market size and forecast trend analysis, 2018 to 2030
Chapter 10. Competitive landscape
10.1. Current developments and impact analysis by key market participants
10.2. Categorization of companies/competitors
10.3. Provider landscape
10.3.1. List of key distributors and sales partners
10.3.2. Key customers
10.4. Company profiles
10.4.1. Company overview
10.4.2. Financial performance
10.4.3. Product benchmarking
10.4.4. Strategic initiatives
For more information about this report, see
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
-
Global cat vaccine market
